Leon, Spain

Manuel Jesus Lopez Nieto

This inventor holds 1 USPTO granted patent. Top assignee: Antibioticos, S.a.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manuel Jesus Lopez Nieto. Retrieved from https://idiyas.com/inventor/manuel-jesus-lopez-nieto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manuel Jesus Lopez Nieto: Innovator in Clavulanic Acid Production

Introduction

Manuel Jesus Lopez Nieto is a notable inventor based in Leon, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the production of clavulanic acid. His innovative work has led to the development of a patented process that enhances the efficiency of producing this important compound.

Latest Patents

Manuel holds a patent for a "Process for the production of clavulanic acid and/or salts thereof." This patent represents a crucial advancement in the pharmaceutical industry, as clavulanic acid is widely used in combination with antibiotics to combat bacterial resistance.

Career Highlights

Manuel is currently employed at Antibioticos, S.A., a company dedicated to the production of antibiotics and other pharmaceutical products. His work at Antibioticos has allowed him to apply his innovative ideas in a practical setting, contributing to the company's success in the industry.

Collaborations

Throughout his career, Manuel has collaborated with talented individuals such as Carmelita Rodriguez Otero and Miguel Angel Moreno Valle. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of new solutions in the field of pharmaceuticals.

Conclusion

Manuel Jesus Lopez Nieto is a distinguished inventor whose work in the production of clavulanic acid has made a significant impact on the pharmaceutical industry. His dedication to innovation and collaboration continues to drive advancements in this vital field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…